Summary

The global surgical devices market is projected to reach USD 296.76 billion by 2031, growing from USD 188.74 billion in 2026, at a CAGR of 9.5% during the forecast period.

The growth of the surgical devices market is primarily driven by the rising prevalence of chronic diseases, increasing aging populations, and growing adoption of minimally invasive and robotic-assisted surgeries, which are increasing global surgical procedure volumes. Significant opportunities exist in the expansion of surgical robotics and rapidly growing ambulatory surgery centers, particularly in emerging markets. However, market growth is challenged by the high capital costs associated with advanced surgical technologies, long equipment replacement cycles, and shortages of skilled surgeons and technical personnel required to effectively operate sophisticated surgical systems and equipment.
“By product, the capital equipment segment is expected to grow at the highest CAGR in the surgical devices market during the forecast period.”
By product, the surgical devices market includes implants, capital equipment, single-use consumables, surgical endoscopy equipment, reusable surgical instruments, and accessories & ancillary products. Among these, the capital equipment segment is expected to grow the fastest during the forecast period. This growth is driven by increasing adoption of surgical robotic systems, advanced imaging and navigation platforms, surgical visualization systems, operating room integration devices, and energy-based surgical technologies. Healthcare providers are investing in these technologies to improve surgical precision, procedural efficiency, patient outcomes, and minimally invasive surgery capabilities. The growing volume of complex surgical procedures, rising demand for robotic-assisted surgery, and expansion of digital operating rooms are further accelerating capital equipment adoption. Additionally, continuous technological advancements incorporating artificial intelligence, real-time imaging, and data analytics are encouraging hospitals to modernize surgical infrastructure, supporting the rapid growth of the capital equipment segment.
“By end user, the ambulatory surgery centers segment is expected to grow at the highest CAGR in the surgical devices market during the forecast period.”
End users categorize the surgical devices market into hospitals, specialty clinics, ambulatory surgery centers, and other end users. Among these, the ambulatory surgery center segment is expected to grow at the highest CAGR in the surgical devices market during the forecast period. This is primarily due to the increasing shift of surgical procedures from hospitals to lower-cost outpatient settings. Advancements in minimally invasive surgery, robotic-assisted procedures, anesthesia techniques, and postoperative care have enabled a growing number of surgeries to be performed safely in ASCs. These facilities offer shorter patient wait times, reduced healthcare costs, faster recovery, and improved operational efficiency compared with traditional hospitals. Additionally, favorable reimbursement trends, increasing patient preference for outpatient care, and rising investments in specialized surgical infrastructure are further driving ASC adoption, supporting strong demand for surgical devices in this setting.
“Asia Pacific is expected to grow at the highest CAGR in the surgical devices market during the forecast period.”
The surgical devices market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The Asia Pacific market is expected to experience the highest CAGR due to the region’s large patient population, rapidly aging demographics, rising chronic disease burden, and expanding healthcare infrastructure. According to the Journal of the American Medical Directors Association (JAMDA), the prevalence of chronic diseases in China reached 81.1% in 2023, increasing demand for surgical interventions across cardiovascular, oncological, orthopedic, and neurological specialties. Additionally, Japan has one of the world's oldest populations, with more than 10% of its population aged 80 years or older, according to the World Economic Forum. Combined with increasing healthcare expenditure, growing adoption of minimally invasive and robotic-assisted surgeries, and improving access to advanced healthcare services, these factors are accelerating demand for surgical devices across the Asia Pacific region.
A breakdown of the primary participants (supply side) for the surgical devices market referred to in this report is provided below:
・By Company Type: Tier 1 - 35%, Tier 2 - 40%, and Tier 3 - 25%
・By Designation: C-level Executives - 45%, Directors - 35%, and Others - 20%
・By Region: North America - 27%, Europe - 25%, Asia Pacific - 30%, Latin America - 8%, and the Middle East & Africa - 10%
Prominent players in the surgical devices market include Medtronic (Ireland), Boston Scientific Corporation (US), B Braun SE (Germany), Johnson& Johnson (US), Stryker (US), Intuitive Surgical Operations, Inc. (US), CONMED Corporation (US), Olympus Corporation (Japan) Integra LifeSciences Corporation (US), Teleflex Incorporated (US), and among others.
Research Coverage
The report analyzes the surgical devices market and estimates its size and future growth potential across segments by product, type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall ostomy dressing market. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
・ Analysis of key drivers (Rising burden of chronic diseases is accelerating long-term demand for surgical devices, the ageing population is increasing surgical intensity and procedure frequency, minimally invasive and robotic surgery are expanding recurring device demand for surgical device), restraints (High capital intensity and long replacement cycles are restraining the adoption of the advanced surgical platforms, shortage of skilled surgeons and technical expertise), opportunities (Growing transition toward minimally invasive and outpatient surgery is expanding demand for disposable surgical devices), and challenges (Product recalls and device-related safety concerns)
・Market Penetration: Extensive information on products offered by the major players in the global surgical devices market
・Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global surgical devices market
・Market Development: Thorough knowledge and analysis of the profitable rising markets by products, type, procedures, end users, and regions
・Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global surgical devices market
・Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical devices market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.3 STUDY SCOPE 32
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 32
1.3.2 INCLUSIONS & EXCLUSIONS 33
1.3.3 YEARS CONSIDERED 34
1.3.4 CURRENCY CONSIDERED 34
1.4 STAKEHOLDERS 35
2 EXECUTIVE SUMMARY 36
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 36
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 37
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 38
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 39
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 40
3 PREMIUM INSIGHTS 41
3.1 SURGICAL DEVICES MARKET OVERVIEW 41
3.2 NORTH AMERICA: SURGICAL DEVICES MARKET, BY END USER 42
3.3 SURGICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 43
3.4 SURGICAL DEVICES MARKET: REGIONAL MIX 43
3.5 SURGICAL DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 44
4 MARKET OVERVIEW 45
4.1 INTRODUCTION 45
4.2 MARKET DYNAMICS 45
4.2.1 DRIVERS 46
4.2.1.1 Rising burden of chronic diseases 46
4.2.1.2 Rapidly aging population 46
4.2.1.3 Minimally invasive and robotic surgery 47
4.2.2 RESTRAINTS 47
4.2.2.1 High capital intensity and long replacement cycles 47
4.2.2.2 Shortage of skilled surgeons and technical expertise 47
4.2.3 OPPORTUNITIES 48
4.2.3.1 Growing transition toward minimally invasive and outpatient surgery 48
4.2.4 CHALLENGES 48
4.2.4.1 Product recalls and device-related safety events 48
 
4.3 UNMET NEEDS & WHITE SPACES 55
4.3.1 UNMET NEEDS IN SURGICAL DEVICES MARKET 55
4.3.2 WHITE SPACE OPPORTUNITIES 56
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 56
4.4.1 INTERCONNECTED MARKETS 56
4.4.2 CROSS-SECTOR OPPORTUNITIES 56
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 57
5 INDUSTRY TRENDS 58
5.1 PORTER’S FIVE FORCES ANALYSIS 58
5.1.1 THREAT OF NEW ENTRANTS 59
5.1.2 THREAT OF SUBSTITUTES 59
5.1.3 BARGAINING POWER OF BUYERS 60
5.1.4 BARGAINING POWER OF SUPPLIERS 60
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.2 MACROECONOMIC OUTLOOK 60
5.2.1 INTRODUCTION 60
5.2.2 GDP TRENDS & FORECAST 61
5.2.3 TRENDS IN MINIMALLY INVASIVE SURGERY (MIS) INDUSTRY 62
5.2.4 TRENDS IN SURGICAL ROBOTS INDUSTRY 63
5.3 SUPPLY CHAIN ANALYSIS 63
5.4 VALUE CHAIN ANALYSIS 64
5.5 ECOSYSTEM ANALYSIS 66
5.6 PRICING ANALYSIS 67
5.6.1 AVERAGE SELLING PRICE TREND OF SURGICAL DEVICES,
BY KEY PLAYER (2023–2025) 67
5.6.2 AVERAGE SELLING PRICE TREND OF SURGICAL DEVICES,
BY REGION (2023–2025) 67
5.7 TRADE ANALYSIS 68
5.7.1 IMPORT SCENARIO (HS CODE 9018) 68
5.7.2 EXPORT DATA (HS CODE 9018) 69
5.8 KEY CONFERENCES & EVENTS, 2026–2027 69
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 70
5.10 INVESTMENT & FUNDING SCENARIO 70
5.11 IMPACT OF 2025 US TARIFFS ON SURGICAL DEVICES MARKET 71
5.11.1 INTRODUCTION 71
5.11.2 KEY TARIFF RATES 72
5.11.3 PRICE IMPACT ANALYSIS 73
5.11.4 IMPACT ON COUNTRIES/REGIONS 73
5.11.4.1 North America 73
5.11.4.2 Europe 73
5.11.4.3 Asia Pacific 73
5.11.5 END-USE INDUSTRY IMPACT 74
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 75
6.1 KEY EMERGING TECHNOLOGIES 75
6.1.1 ROBOTIC-ASSISTED & COMPUTER-ASSISTED SURGICAL SYSTEMS 75
6.1.2 AI-ENABLED SURGICAL SOFTWARE, ANALYTICS, AND SMART DEVICE INTEGRATION 75
6.2 COMPLEMENTARY TECHNOLOGIES 75
6.2.1 DIGITAL SURGICAL WORKFLOW, TRAINING, AND CONNECTED OR ECOSYSTEMS 76
6.3 TECHNOLOGY/PRODUCT ROADMAP 76
6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 76
6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 76
6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 77
6.4 PATENT ANALYSIS 78
6.4.1 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 79
6.5 FUTURE APPLICATIONS 79
6.5.1 AI-ENABLED ROBOTIC & COMPUTER-ASSISTED SURGERY 79
6.5.2 CONNECTED OPERATING ROOM & DIGITAL SUPPORT ECOSYSTEMS 80
6.6 IMPACT OF AI/GEN AI ON SURGICAL DEVICES MARKET 80
6.6.1 TOP USE CASES & MARKET POTENTIAL 80
6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN SURGICAL DEVICES MARKET 81
6.6.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 81
6.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN SURGICAL DEVICES MARKET 82
7 SUSTAINABILITY & REGULATORY LANDSCAPE 83
7.1 REGIONAL REGULATIONS & COMPLIANCE 83
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
7.1.2 INDUSTRY STANDARDS 85
7.2 SUSTAINABILITY INITIATIVES 86
7.2.1 CARBON IMPACT & ECO-APPLICATIONS OF SURGICAL DEVICES MARKET 86
7.2.1.1 Carbon impact reduction 86
7.2.1.2 Eco-applications 86
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 87
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 87
7.5 REIMBURSEMENT ANALYSIS 88
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 89
8.1 DECISION-MAKING PROCESS 89
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 89
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
8.2.2 KEY BUYING CRITERIA 90
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 91
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 91
8.5 MARKET PROFITABILITY 91
8.5.1 REVENUE POTENTIAL 92
8.5.2 COST DYNAMICS 92
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 92
9 SURGICAL DEVICES MARKET, BY TYPE 93
9.1 INTRODUCTION 94
9.2 SOFT TISSUE SURGICAL DEVICES 94
9.2.1 HIGH PROCEDURE VOLUMES ACROSS SOFT TISSUE SURGERIES TO DRIVE DOMINANCE 94
9.3 HARD TISSUE SURGICAL DEVICES 95
9.3.1 RISING BURDEN OF MUSCULOSKELETAL DISORDERS AND GROWING ADOPTION OF ADVANCED ORTHOPEDIC TECHNOLOGIES TO SUPPORT DEMAND 95
9.4 HYBRID PLATFORMS 97
9.4.1 GROWING DEMAND FOR VERSATILE SURGICAL TECHNOLOGIES TO SUPPORT SEGMENTAL GROWTH 97
10 SURGICAL DEVICES MARKET, BY PRODUCT 98
10.1 INTRODUCTION 99
10.2 IMPLANTS 99
10.2.1 ORTHOPEDIC & SPORTS MEDICINE IMPLANTS 101
10.2.1.1 High procedure volumes to drive demand for orthopedic & sports medicine implants 101
10.2.2 CARDIOVASCULAR IMPLANTS 102
10.2.2.1 High burden of cardiovascular diseases and growing need for structural heart interventions to support demand 102
10.2.3 SPINAL IMPLANTS 103
10.2.3.1 Rising burden of degenerative spine disorders to support spinal implant demand 103
10.2.4 NEUROSURGICAL IMPLANTS 104
10.2.4.1 Expanding neurological and cerebrovascular disease burden to drive neurosurgical implant demand 104
10.2.5 DENTAL IMPLANTS 105
10.2.5.1 Large oral disease and tooth-loss burden to support market growth 105
10.2.6 SOFT TISSUE & MESH IMPLANTS 106
10.2.6.1 Growing hernia procedure volumes and abdominal wall reconstruction needs to drive mesh implant adoption 106
10.2.7 OPHTHALMIC IMPLANTS 107
10.2.7.1 Growing number of cataract surgeries worldwide to continue to support market growth 107
10.2.8 OTHER SPECIALTY IMPLANTS 109
10.3 CAPITAL EQUIPMENT 110
10.3.1 SURGICAL ROBOTIC SYSTEMS 111
10.3.1.1 Rising minimally invasive procedure volumes and hospital robotic capacity expansion to drive demand 111
10.3.2 IMAGING & SURGICAL NAVIGATION SYSTEMS 112
10.3.2.1 Demand for real-time guidance, accuracy, and lower radiation exposure to support adoption 112
10.3.3 ENERGY GENERATORS & PLATFORMS 113
10.3.3.1 Persistent need for precise cutting, coagulation, and bleeding control to support demand 113
10.3.4 OR INTEGRATION & VISUALIZATION SYSTEMS 115
10.3.4.1 Data visibility, intraoperative image management, and digital workflow control to support demand 115
10.3.5 SURGICAL MICROSCOPES & EXOSCOPES 116
10.3.5.1 High-magnification visualization, surgeon ergonomics, and broader microsurgical use to boost growth 116
10.3.6 INSUFFLATORS & FLUID MANAGEMENT SYSTEMS 117
10.3.6.1 Expanding minimally invasive and endoscopic procedure volumes to propel market growth 117
10.4 SINGLE-USE CONSUMABLES 118
10.4.1 SURGICAL STAPLERS & CLIP APPLIERS 119
10.4.1.1 Growing gastrointestinal, bariatric, and colorectal surgery volumes to fuel growth 119
10.4.2 SUTURES & WOUND CLOSURE PRODUCTS 120
10.4.2.1 Rising surgical procedure volumes and trauma-related wound management needs to fuel market 120
10.4.3 SINGLE-USE ENERGY DEVICES 122
10.4.3.1 Growing minimally invasive and robot-assisted surgery volumes to drive utilization of single-use energy devices 122
10.4.4 TROCARS & ACCESS DEVICES 123
10.4.4.1 Rising minimally invasive surgery volumes across multiple specialties to contribute to market growth 123
10.4.5 HEMOSTATS & SEALANTS 124
10.4.5.1 Growing volumes of cardiovascular, orthopedic, and complex surgical procedures to drive market growth 124
10.5 SURGICAL ENDOSCOPY EQUIPMENT 125
10.5.1 RIGID ENDOSCOPES 127
10.5.1.1 Expanding minimally invasive surgical procedure volumes across multiple specialties to fuel growth 127
10.5.2 FLEXIBLE ENDOSCOPES 128
10.5.2.1 Growing volumes of cardiovascular, orthopedic, and complex surgical procedures to boost demand 128
 
10.6 REUSABLE SURGICAL INSTRUMENTS 129
10.6.1 POWERED INSTRUMENTS 130
10.6.1.1 Increasing complex reconstructive procedure volumes to drive demand 130
10.6.2 HANDHELD INSTRUMENTS 132
10.6.2.1 Broad utilization across general, cardiovascular, oncologic, and specialty surgeries to sustain demand 132
10.7 ACCESSORIES & ANCILLARY PRODUCTS 133
11 SURGICAL DEVICES MARKET, BY PROCEDURE 135
11.1 INTRODUCTION 136
11.2 ORTHOPEDICS 136
11.2.1 RISING BURDEN OF MUSCULOSKELETAL DISORDERS TO DRIVE GROWTH OF ORTHOPEDIC SURGICAL DEVICES SEGMENT 136
11.3 CARDIOVASCULAR 137
11.3.1 RISING CARDIOVASCULAR DISEASE BURDEN TO DRIVE SUSTAINED DEMAND FOR CARDIOVASCULAR SURGICAL DEVICES 137
11.4 GENERAL SURGERY 139
11.4.1 HIGH SURGICAL PROCEDURE VOLUMES ACROSS MULTIPLE SPECIALTIES TO DRIVE DEMAND FOR GENERAL SURGERY DEVICES 139
11.5 GASTROINTESTINAL 140
11.5.1 RISING BURDEN OF GASTROINTESTINAL DISORDERS TO DRIVE DEMAND FOR GASTROINTESTINAL SURGICAL PROCEDURES 140
11.6 NEUROLOGY 141
11.6.1 RISING BURDEN OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH 141
11.7 GYNECOLOGY 142
11.7.1 GROWING BURDEN OF GYNECOLOGICAL CANCERS TO DRIVE DEMAND FOR GYNECOLOGICAL SURGICAL PROCEDURES 142
11.8 UROLOGY 143
11.8.1 RISING PREVALENCE OF CHRONIC KIDNEY DISEASE AND UROLOGICAL CANCERS TO BOOST MARKET 143
11.9 DENTAL 144
11.9.1 GROWING DEMAND FOR DENTAL IMPLANTS AND COSMETIC DENTISTRY TO ACCELERATE SEGMENT GROWTH 144
11.10 ENT 145
11.10.1 RISING INCIDENCE OF ENT DISORDERS TO DRIVE GROWTH 145
11.11 PEDIATRICS 146
11.11.1 RISING ULCERATIVE COLITIS PREVALENCE TO DRIVE SEGMENTAL GROWTH 146
11.12 OTHER PROCEDURES 147
12 SURGICAL DEVICES MARKET, BY END USER 148
12.1 INTRODUCTION 149
12.2 HOSPITALS 149
12.2.1 HIGH SURGICAL PROCEDURE VOLUMES AND ADOPTION OF ADVANCED SURGICAL TECHNOLOGIES TO SUPPORT HOSPITAL DOMINANCE 149
12.3 AMBULATORY SURGICAL CENTERS 150
12.3.1 GROWING SHIFT TOWARD COST-EFFECTIVE OUTPATIENT SURGERIES AND MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH 150
12.4 SPECIALTY CLINICS 151
12.4.1 RISING DEMAND FOR SPECIALIZED SURGICAL CARE TO SUPPORT SEGMENT GROWTH 151
12.5 OTHER END USERS 152
13 SURGICAL DEVICES MARKET, BY REGION 154
13.1 INTRODUCTION 155
13.2 NORTH AMERICA 156
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 156
13.2.2 US 162
13.2.2.1 US to hold major share in North American surgical devices market 162
13.2.3 CANADA 166
13.2.3.1 Growing chronic disease burden and aging population to support Canada's market growth 166
13.3 EUROPE 170
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 170
13.3.2 GERMANY 175
13.3.2.1 Germany held major share in European surgical devices market 175
13.3.3 UK 178
13.3.3.1 Growing burden of musculoskeletal and cardiovascular diseases to support surgical device demand in UK 178
13.3.4 FRANCE 183
13.3.4.1 Rising burden of cardiovascular disease and cancer to aid market growth 183
13.3.5 ITALY 186
13.3.5.1 Rising cancer burden and growing demand for advanced surgical care support to drive demand 186
13.3.6 SPAIN 191
13.3.6.1 growing aging population and rising burden of chronic diseases to aid market growth 191
13.3.7 REST OF EUROPE 194
13.4 ASIA PACIFIC 199
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 199
13.4.2 CHINA 204
13.4.2.1 China held major share of Asia Pacific surgical devices market 204
13.4.3 JAPAN 208
13.4.3.1 Rising aging population and rising burden of cancer to drive market growth 208
13.4.4 INDIA 212
13.4.4.1 Rising chronic disease burden, aging population, and expanding healthcare access to drive rapid market growth 212
 
13.4.5 AUSTRALIA 217
13.4.5.1 High burden of cardiovascular and musculoskeletal disorders to support surgical device demand 217
13.4.6 SOUTH KOREA 221
13.4.6.1 Aging population and rising cancer burden to support surgical device demand in South Korea 221
13.4.7 REST OF ASIA PACIFIC 225
13.5 LATIN AMERICA 229
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 229
13.5.2 BRAZIL 233
13.5.2.1 Brazil to holds largest share in Latin American market 233
13.5.3 MEXICO 238
13.5.3.1 Rising chronic disease burden and growing medical tourism to support market expansion in Mexico 238
13.5.4 REST OF LATIN AMERICA 241
13.6 MIDDLE EAST & AFRICA 246
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 246
13.6.2 GCC COUNTRIES 251
13.6.2.1 Rising cancer incidence and strong healthcare infrastructure to aid market growth 251
13.6.3 REST OF MIDDLE EAST & AFRICA 255
14 COMPETITIVE LANDSCAPE 259
14.1 INTRODUCTION 259
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 259
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL DEVICES MARKET 259
14.3 REVENUE ANALYSIS, 2021–2025 261
14.4 MARKET SHARE ANALYSIS, 2025 261
14.4.1 GLOBAL SURGICAL ROBOTS MARKET SHARE ANALYSIS, 2025 261
14.4.2 GLOBAL ENERGY GENERATORS MARKET SHARE ANALYSIS, 2025 262
14.4.3 GLOBAL SURGICAL SUTURES MARKET SHARE ANALYSIS, 2025 263
14.4.4 GLOBAL SURGICAL STAPLERS MARKET SHARE ANALYSIS, 2025 263
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 264
14.5.1 STARS 264
14.5.2 EMERGING LEADERS 264
14.5.3 PERVASIVE PLAYERS 265
14.5.4 PARTICIPANTS 265
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 266
14.5.5.1 Company footprint 266
14.5.5.2 Region footprint 267
14.5.5.3 Type footprint 268
 
14.5.5.4 Product footprint 269
14.5.5.5 Procedure footprint 270
14.5.5.6 End-user footprint 271
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 272
14.6.1 PROGRESSIVE COMPANIES 272
14.6.2 RESPONSIVE COMPANIES 272
14.6.3 DYNAMIC COMPANIES 273
14.6.4 STARTING BLOCKS 273
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 274
14.6.5.1 Detailed list of key startups/SMEs 274
14.6.5.2 Competitive benchmarking of key startups/SMEs 275
14.7 COMPANY VALUATION & FINANCIAL METRICS 276
14.7.1 FINANCIAL METRICS 276
14.7.2 COMPANY VALUATION 276
14.8 BRAND/PRODUCT COMPARISON 277
14.9 COMPETITIVE SCENARIO 277
14.9.1 PRODUCT LAUNCHES & APPROVALS 277
14.9.2 DEALS 278
14.9.3 EXPANSIONS 279
15 COMPANY PROFILES 280
15.1 KEY PLAYERS 280
15.1.1 MEDTRONIC PLC 280
15.1.1.1 Business overview 280
15.1.1.2 Products offered 281
15.1.1.3 Recent developments 282
15.1.1.3.1 Product approvals 282
15.1.1.3.2 Other developments 283
15.1.1.4 MnM view 283
15.1.1.4.1 Right to win 283
15.1.1.4.2 Strategic choices 283
15.1.1.4.3 Weaknesses & competitive threats 283
15.1.2 JOHNSON & JOHNSON 284
15.1.2.1 Business overview 284
15.1.2.2 Products offered 285
15.1.2.3 Recent developments 287
15.1.2.3.1 Product launches & approvals 287
15.1.2.3.2 Deals 287
15.1.2.3.3 Expansions 288
 
15.1.2.4 MnM view 288
15.1.2.4.1 Right to win 288
15.1.2.4.2 Strategic choices 289
15.1.2.4.3 Weaknesses & competitive threats 289
15.1.3 STRYKER CORPORATION 290
15.1.3.1 Business overview 290
15.1.3.2 Products offered 291
15.1.3.3 Recent developments 292
15.1.3.3.1 Deals 292
15.1.4 B. BRAUN 293
15.1.4.1 Business overview 293
15.1.4.2 Products offered 294
15.1.4.3 Recent developments 295
15.1.4.3.1 Deals 295
15.1.4.3.2 Expansions 295
15.1.4.4 MnM view 296
15.1.4.4.1 Right to win 296
15.1.4.4.2 Strategic choices 296
15.1.4.4.3 Weaknesses & competitive threats 296
15.1.5 INTUITIVE SURGICAL 297
15.1.5.1 Business overview 297
15.1.5.2 Products offered 298
15.1.5.3 Recent developments 299
15.1.5.3.1 Product approvals 299
15.1.5.3.2 Expansions 299
15.1.6 SIEMENS HEALTHINEERS AG 300
15.1.6.1 Business overview 300
15.1.6.2 Products offered 301
15.1.6.3 Recent developments 302
15.1.6.3.1 Product launches & approvals 302
15.1.6.3.2 Expansions 303
15.1.7 OLYMPUS CORPORATION 304
15.1.7.1 Business overview 304
15.1.7.2 Products offered 305
15.1.7.3 Recent developments 306
15.1.7.3.1 Product launches & approvals 306
15.1.8 ZIMMER BIOMET HOLDINGS, INC. 308
15.1.8.1 Business overview 308
15.1.8.2 Products offered 309
15.1.8.3 Recent developments 311
15.1.8.3.1 Product launches & approvals 311
15.1.8.3.2 Deals 311
15.1.9 BOSTON SCIENTIFIC CORPORATION 312
15.1.9.1 Business overview 312
15.1.9.2 Products offered 313
15.1.9.3 Recent developments 314
15.1.9.3.1 Product launches & approvals 314
15.1.10 CONMED CORPORATION 315
15.1.10.1 Business overview 315
15.1.10.2 Products offered 316
15.1.10.3 Recent developments 317
15.1.10.3.1 Product launches 317
15.1.10.3.2 Expansions 318
15.2 OTHER PLAYERS 319
15.2.1 BAXTER INTERNATIONAL INC. 319
15.2.2 HEALTHIUM MEDTECH LIMITED 320
15.2.3 ABBOTT 321
15.2.4 GLOBUS MEDICAL, INC. 322
15.2.5 BECTON, DICKINSON AND COMPANY 323
15.2.6 SMITH+NEPHEW 324
15.2.7 MICROPORT SCIENTIFIC CORPORATION 325
15.2.8 INTEGRA LIFESCIENCES 326
15.2.9 COOK MEDICAL 327
15.2.10 ARTHREX, INC. 328
15.2.11 ADVANCED MEDICAL SOLUTIONS GROUP PLC 329
15.2.12 ASPEN SURGICAL PRODUCTS, INC. 330
15.2.13 FUJIFILM HOLDINGS CORPORATION 332
15.2.14 KARL STORZ 333
15.2.15 STERIS PLC 334
16 RESEARCH METHODOLOGY 335
16.1 RESEARCH DATA 335
16.1.1 SECONDARY DATA 336
16.1.1.1 Key data from secondary sources 337
16.1.2 PRIMARY DATA 338
16.1.2.1 Key data from primary sources 339
16.1.2.2 Key industry insights 340
16.2 MARKET SIZE ESTIMATION 341
16.3 MARKET BREAKDOWN & DATA TRIANGULATION 346
16.4 MARKET RANKING ANALYSIS 347
16.5 STUDY ASSUMPTIONS 347
 
16.6 RESEARCH LIMITATIONS 347
16.6.1 METHODOLOGY-RELATED LIMITATIONS 347
16.6.2 SCOPE-RELATED LIMITATIONS 347
16.7 RISK ASSESSMENT 348
17 APPENDIX 349
17.1 DISCUSSION GUIDE 349
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 356
17.3 CUSTOMIZATION OPTIONS 358
17.4 RELATED REPORTS 358
17.5 AUTHOR DETAILS 359